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BACKGROUND: Predicting the risk of in-hospital mortal-
ity on admission is challenging but essential for risk strat-
ification of patient outcomes and designing an appropri-
ate plan-of-care, especially among transferred patients.
OBJECTIVE: Develop a model that uses administrative
and clinical data within 24 h of transfer to predict 30-day
in-hospital mortality at an Academic Health Center
(AHC).
DESIGN: Retrospective cohort study. We used 30 pu-
tative variables in a multiple logistic regression mod-
el in the full data set (n = 10,389) to identify 20
candidate variables obtained from the electronic
medical record (EMR) within 24 h of admission that
were associated with 30-day in-hospital mortality
(p < 0.05). These 20 variables were tested using mul-
tiple logistic regression and area under the curve
(AUC)–receiver operating characteristics (ROC) analy-
sis to identify an optimal risk threshold score in a
randomly split derivation sample (n = 5194) which
was then examined in the validation sample (n =
5195).
PARTICIPANTS: Ten thousand three hundred eighty-
nine patients greater than 18 years transferred to the
Indiana University (IU)–Adult Academic Health Center
(AHC) between 1/1/2016 and 12/31/2017.
MAINMEASURES:Sensitivity, specificity, positive predic-
tive value, C-statistic, and risk threshold score of the
model.
KEY RESULTS: The final model was strongly discrimina-
tive (C-statistic = 0.90) and had a good fit (Hosmer-Leme-
show goodness-of-fit test [X2 (8) =6.26, p = 0.62]). The
positive predictive value for 30-day in-hospital death was
68%; AUC-ROC was 0.90 (95% confidence interval 0.89–
0.92, p < 0.0001). We identified a risk threshold score of
−2.19 that had amaximumsensitivity (79.87%) and spec-
ificity (85.24%) in the derivation and validation sample
(sensitivity: 75.00%, specificity: 85.71%). In the validation
sample, 34.40% (354/1029) of the patients above this
threshold died compared to only 2.83% (118/4166)
deaths below this threshold.
CONCLUSION: This model can use EMR and administra-
tive data within 24 h of transfer to predict the risk of 30-
day in-hospital mortality with reasonable accuracy
among seriously ill transferred patients.
KEY WORDS: mortality prediction model; in-hospital mortality; serious
illness; serious illness communication; risk stratification; clinical
decision-making.
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INTRODUCTION
Identifying patients with serious illness and predicting the risk
of in-hospital mortality is challenging,1–4 especially among a
diverse group of patients transferred between facilities for a
higher level of care. Early assessment of serious illness and
risk of mortality is essential for risk-adjustment for bench-
marking5 and designing an appropriate plan-of-care including
early conversations about patient outcomes and goals of care.3,
4 Transfer patients are known to be sicker, use more resources,
and have poorer outcomes.6–9 They are medically more com-
plex than initially estimated and can cause inaccurate bench-
marking in centers receiving large numbers of transfer patients
due to inadequate risk stratification.10 Clinicians may be chal-
lenged with the implications of early risk assessments, given
their own limited prognostic accuracy, biases, and discomfort
in the setting of patient emotions may defer serious illness
communications (SIC) leading to a goal-incongruent care
including intensive care unit (ICU) escalations and interven-
tions with poor outcomes.2, 4 Despite its recognized value, SIC
are often delayed towards the end of the disease trajectory after
exhausting all life-sustaining treatments leading to patient and
family dissatisfaction and under-utilization of palliative care
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and hospice services.4, 11, 12 Recognizing these complexities
clinicians have expressed an interest in adopting evidence-
based clinical prediction models to increase their prognostic
confidence in the end-of-life care.13
Available models predicting mortality are often limited to
ICU settings,14 are condition-specific,15–18 or predict deaths
after hospital discharge.19–21 Multiple early warning systems
(EWS) have been developed that use vital sign abnormalities
prior to clinical deterioration with efforts to predict in-hospital
mortality, but these models are limited by poor sensitivity,
poor positive predictive value, and low reproducibility.22–24
Using machine learning, a real-time electronic medical record
(EMR)–based inpatient mortality EWS was successful in
identifying high-risk patients 24–48 h prior to death with
improved sensitivity and specificity,25 and our goal was to
identify patients for early interventions at the beginning of the
hospitalization and before a crisis occurs. One validated in-
hospital mortality model5, 26, 27 has an acceptable sensitivity,
specificity, and predictive value that included transferred
patients and direct admissions within the same health care
system and used the same EMR. We were unable to replicate
this approach due to lack of integration of information systems
of transferring facilities into our EMR and variations in hos-
pital practices of the sending facilities.28 A review of existing
models demonstrated that a model that is feasible for our
institution did not yet exist.
This study aimed to develop a model using readily available
administrative and clinical data gathered from the EMRwithin
24 h of transfer to identify patients at a high risk of 30-day in-
hospital mortality. Our goal is to predict risk for all-cause in-
hospital mortality for transferred patients across all levels of
care to support clinicians in decision-making and hospitals in
risk-adjustment of patient outcomes.5, 26, 28, 29 The develop-
ment of this model is the first step in the Indiana University
(IU) Learning Health System Initiative (IU-LHSI) aimed at
improving health care service delivery and outcomes for seri-




The IU Institutional Review Board (IRB) deemed this work to
constitute quality improvement (QI) and exempted the study
from IRB oversight.
RESEARCH SETTING
The Indiana University Health (IU Health) System is the
largest and the most comprehensive health system in Indiana,
comprising of 18 hospitals and partnering with Indiana Uni-
versity School of Medicine. The IU-Academic Health Center
(IU-AHC) is a component of IU Health System that includes
Methodist Hospital and University Hospital, which is a large
tertiary center with about 50% of acute to acute transfers from
within IU Health system and from facilities that are not inte-
grated into its EMR. In 2019 IU-AHC had 93,633 emergency
department (ED) visits, 14,377 transfers from peripheral hos-
pitals, and 33,849 admissions.
Study Population
We identified 10,389 patients greater than 18 years old who
were transferred from peripheral ED or other facilities to IU-
AHC between 1/1/2016 and 12/31/2017. Any patients admit-
ted from the IU-AHC ED were excluded.
Data Collection
Administrative data elements recorded within the first 24 h
after transfer were obtained from the IU Health Data Ware-
house, a combination of clinical (Cerner) and billing data
using a data collection sheet (Appendix 1). Clinical data
included vital signs, laboratory values, demographics, home
medications, and health care utilization data. Billing data
included Medicare severity–diagnosis-related group (MS-
DRG) and International classification of diseases, tenth revi-
sion, clinical modification (ICD-10-CM). Diagnosis and visit
data from up to 2 years prior to the index admission were
obtained from the Indiana Health Information Exchange
(IHIE), a statewide data system that connects to over 100
hospitals from 38 different health systems and includes clini-
cal, laboratory, and diagnostic data for more than 15 million
patients across Indiana.31, 32
Variables
Based on “PubMed” database search using terms “in-hospital
mortality,” “in-hospital deaths,” and “inter-hospital transfers”
and after review of other mortality prediction models, we
identified 30 putative variables (see Table 1) for inclusion in
the mortality model.5, 14, 15, 18, 26 Demographic data included
age and gender. Admit type was defined as an emergency,
urgent, and routine. The level of admission was defined as the
initial location of admission (progressive care unit/PCU, crit-
ical care, regular floor). Admitting service was broadly cate-
gorized as medicine, surgery, critical care medicine, and ob-
stetrics-gynecology. Utilization data included the total number
of encounters within the IU Health system 90 days prior to the
admission of interest. We used the first recorded vital signs,
laboratory values, and Glasgow coma scale. Surgery within
24 h of admission was noted. Polypharmacy was defined as
greater than five home medications at the time of admission of
interest33 and was validated with a random check of fifty
patient charts for accuracy. Respiratory support in the first
24 h was defined as noninvasive positive pressure ventilation
support (NIPPV) or ventilation support. NIPPV included high
flow oxygen, bilevel positive airway pressure (BIPAP), or
continuous positive airway pressure (CPAP). Vasopressor
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use in the first 24 h was identified as present or absent.
Charlson comorbidity index on the day of the admission of
interest was retrospectively constructed from the admission
and IHIE data using Deyo ICD-9 codes and their ICD-10
mappings.34 Four laboratory values had missing data rates
>30% (bilirubin, albumin, base, INR) and were recorded as
3-level categorical variables (abnormal, normal, or missing).
For patients with multiple transfers to IU-AHC during the
study period, the admission of interest was defined as the last
inpatient encounter.
Our main dependent variable was 30-day in-hospital mor-
tality, defined as any inpatient death within 30 days of the
admission of interest. Six transferred patients who died in the
hospital later than 30 days of inpatient stay were excluded.
Patients who died outside the hospital after discharge were not
included in the in-hospital death group even if the post-
discharge death was within 30 days.
Statistical Analysis
The 30 variables that were selected from the PubMed search
were used in an initial multiple logistic regression model in the
full data set to identify any candidate variables that were
significantly associated with 30-day in-hospital mortality
(p < 0.05) (Table 1). The cohort (10,389) was then randomly
divided into derivation (n = 5194) and validation (n = 5195)
samples, such that each sample had an equivalent rate of 30-
day in-hospital mortality (9.09%). We used the derivation
sample to develop the final model and validation sample to
test the accuracy of the final model. Comparisons of signifi-
cant variables in the initial full sample were conducted in the
derivation sample between dead and survived groups, inde-
pendent t tests were used for continuous variables, and chi-
square tests were used for dichotomous variables (Table 2).
In the next step, variables significantly related to 30-day in-
hospital mortality in the full sample were tested in relation to
30-day inpatient death in the derivation sample (Table 3). To
evaluate this model, area under the curve–receiver operating
characteristics (AUC-ROC) (Fig. 1), sensitivity, specificity,
and positive predictive values at varying thresholds of speci-
ficity in the derivation sample were inspected (Table 4). We
then applied the optimal threshold score (highest combined
sensitivity and specificity values) from the derivation model to
determine sensitivity and specificity within the validation
model (Table 5).
RESULTS
In our total sample of 944 deaths, 56% of deaths occurred
within the first seven days from the date of the transfer. On
admission, 64.5% patients had do not resuscitate (DNR) sta-
tus, 2.6% patients had limited code status, 7.2% patients had
full code status, and 25% patients did not have a documented
code status. Among the patients with a 30-day in-hospital
mortality, only 11% of patients had a palliative care consulta-
tion, 4.6% were enrolled in hospice, and 3.4% were transi-
tioned into hospice care after a palliative care consultation.
The average days from the admission of interest to obtain a
palliative care consultation was 7.37 days, and a hospice
consultation was 9.18 days. Sepsis contributed to 18.64% of
deaths; other causes are shown in Appendix 2.
Using a multiple regression model, we identified 20 candi-
date variables in the full data set that were statistically signif-
icant and associated with 30-day in-hospital mortality
(p < 0.05) (Table 1). Based on comparisons between died
and survived groups, patients who died were older, had fewer
pre-admission encounters within the IU system, were less
likely to have surgery, had higher CCI scores, had lower
Glasgow coma scale, and were more likely admitted to a
Table 1 SAS output from multiple logistic regression model
predicting 30-day inpatient death from 30 variables in the full data
set (n = 10,389)




Sex, dichotomous 1 1.9157 0.1663
Age at admission (years),
continuous
1 106.9717 <.0001
Admit type (emergency, routine,
urgent), categorical
2 4.8013 0.0907
Admitting service (critical care
medicine), categorical
1 150.5736 <.0001
Level of care (critical, PCU,
regular), categorical
2 3.2050 0.2014
Number of encounters 90 days
prior, continuous
1 61.5615 <.0001
Previous admission in last
3 months, dichotomous
1 3.6690 0.0554






Glasgow coma scale, continuous 1 80.1054 <.0001
Polypharmacy, dichotomous 1 181.2054 <.0001
Vent or NIPPV in the first 24 h,
dichotomous
1 91.9020 <.0001
Any vasopressor use in the first
24 h, dichotomous
1 8.5903 0.0034
First creatinine, mg/dl, continuous 1 0.0037 0.9517














First BUN, mg/dl, continuous 1 8.1659 0.0043
First respiratory rate per minute,
continuous
1 13.4407 0.0002
First systolic blood pressure in
mmHg, continuous
1 4.2214 0.0399
First diastolic blood pressure in
mmHg, continuous
1 0.7228 0.3952
First temperature in Celsius,
continuous
1 18.9562 <.0001
First white blood count, K/cumm,
continuous
1 29.8458 <.0001
First T. Bilirubin, mg/dl,
continuous
2 11.3306 0.0035
First albumin, gm/dl, continuous 2 17.4706 0.0002
First base excess, continuous 2 25.7125 <.0001
First INR, continuous 2 12.1855 0.0023
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critical care unit with ventilator and vasopressor use (Table 2).
Those who died also had a higher heart rate and respiratory
rates on admission but slightly lower temperatures and more
often had abnormal labs (Table 2). Fewer patients who died
had polypharmacy (Table 2). The 20 candidate variables iden-
tified in the full data sample were noted to be statistically
significant in the derivation sample as well (Table 3).
The final logistic model tested in the derivation sample was
strongly discriminative (C-statistic = 0.90) and had a good fit
(the Hosmer-Lemeshow goodness-of-fit test, [X2 (8)=6.26,
p = 0 .62]. As shown in Figure 1, the AUC for 30-day in-
hospital death in the derivation sample was 0.90 (95% confi-
dence interval [0.89, 0.92], p < 0.0001). The median predicted
score was −0.59 (range = −5.31, 5.16) for the cases that died,
and was −3.74 (range = −14.77, 3.56) for the cases that
survived. The positive predictive value was 68.00% (170/
[170 + 80]). Table 4 shows model characteristics in the deri-
vation sample at various levels of specificity. An outcome
score of −2.19 (probability = 0.10), sensitivity (79.87%), and
specificity (85.24%) had the greatest combined sum. In the
validation sample, this threshold score of −2.19 resulted in a
sensitivity of 75.00% and specificity of 85.71% (Table 5). At
values above this threshold, 34.40% (354/1029) of patients
died within 30 days; below this threshold, only 2.83% (118/
4166) of the patients died.
DISCUSSION
In this study, we developed a model using 20 variables readily
available from the administrative and EMR data in the first 24 h
of transfer that was strongly predictive of 30-day in-hospital
mortality (C-statistic 0.90). This work is a significant contribu-
tion as transfer patients have higher inpatient mortality, and very
few prediction models for unselected transferred cohorts have
been shown to have a high discriminatory ability and clinical
utility.28, 35 We found that a threshold score of −2.19 identified
a group of patients with a high likelihood of 30-day in-hospital
mortality with a reasonable specificity and sensitivity.
Our study differs from prior studies that have developed
mortality prediction models solely using EMR-generated var-
iables as we also included clinical data obtained from EMR
very early after the transfer, CCI scores, and health care
utilization estimates obtained from claims data and data from
health information exchange(HIE) sources.36, 37 Some varia-
bles that were associated with in-hospital mortality were those
that would be expected to be associated with increased mor-
tality, for example, older age, admission to an intensive care
setting, use of vasopressors, intubation, and abnormal labora-
tory values; our model may have performed well because of
the broader range of information we included to supplement a
clinician’s judgment: utilization data, comorbidity scores, and
polypharmacy. Some associations were counter-intuitive, in-
cluding fewer patient encounters prior to transfer and less
polypharmacy. Because our sample only included transfer
patients, we may have missed utilization events at outside
hospitals not participating in the IHIE which could contribute
to lower number of patient encounters. Alternatively, residents
of remote areas or patients with other barriers to health care
access could result in lower patient encounters and untreated
underlying medical conditions. We expected polypharmacy
would be associated with increased mortality but found that
patients with polypharmacy at the time of transfer had a higher
survival rate, perhaps reflecting more access to care prior to
the admission of interest.38 Abnormal laboratory values were
also associated with mortality in largely expected ways, but
the analysis of albumin, base, bilirubin, and INR was compli-
cated due to the amount of missing data for these four varia-
bles (Table 3). Laboratory values may not be ordered due to
lack of clinical rationale, as an aspect of less aggressive care,
Table 2 Characteristics of Participants in Derivation Sample (n =
5194) with bivariate comparisons











Number of Encounters, mean
(SD): continuous
1.68 (1.28) 2.24 (2.09) <.0001
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*Charlson comorbidity index. †Normal values for bilirubin (0–1),
albumin (3.5–5.0), base (−2.0–2.0), and INR (0.83–1.22) were used to
categorize these variables as normal, abnormal, or as missing
Mahendraker et al.: Mortality Predictive Model for Transfer Patients JGIM
or were available from the transferring center and not repeated
on admission. We did note a higher risk of mortality among
those with missing bilirubin data, and this may suggest that it
is prudent to order bilirubin early on admission in clinically
relevant patients.
Our model has several potential implications for interven-
tions in patients with serious illness, including identification of
high-risk patients for additional clinical review and as a pos-
sible trigger for SIC.12According to a recent national experts’
consensus, EMR should reduce the burden of data capture on
clinicians and hospital systems by meaningful communication
of SIC12; the present model could be used for this purpose. A
real-time mortality predicting EWS was prospectively validat-
ed to predict patients at high risk for inpatient mortality using
machine learning methods and identified 40% of patients 24 to
48 h before their death but only 11% of patients 3 to 7 days
before death.25 Our aim was not to develop continuous real-
time mortality predicting model but to identify patients at risk
for in-hospital death at the beginning of admission to facilitate
SIC interventions and target efforts to improve in-hospital
mortality outcomes before a crisis occurs. Another study de-
veloped an EMR model of 6-month mortality using sophisti-
cated machine learning techniques to trigger early palliative
care consults on hospital day 2, increasing palliative care
referrals.20 Similarly, we are planning a pilot study to deploy
our model as a part of the IU-LHSI project to identify patients
at high risk of in-hospital mortality who may benefit from
formal SIC interventions, including formal palliative care and
hospice consultations as appropriate. Although the absolute
percentage of deaths identified with this model is around 34%
for those with a score above the threshold, this positive pre-
dictive value is reasonable for identifying patients that may
benefit from early palliative care and hospice intervention. The
need for this type of intervention is evidenced in our study by
the observation of a lower proportion of patients receiving
palliative and hospice care consultations prior to their death.
Because SIC includes shared decision-making after discussing
prognostic estimates in the setting of patient expectations,
goals, values,12 and designing a plan-of-care before a crisis
occurs, our model is especially desired as a potential EMR
intervention in transferred patients triggered 24 h after admis-
sion. Our model is also unique as it illustrates the potential
benefit of meaningful use of HIE by facilitating the exchange
Table 3 Summary of Multivariate Analysis Predicting 30-day Inpatient Death in Derivation Sample (n = 5194)
Parameter Estimate Standard error p value Odds ratio (OR) 95% confidence
interval for OR
Age at admission (years) 0.032 0.0042 <.0001 1.033 1.024 1.041
Number of encounters −0.342 0.052 <.0001 0.711 0.641 0.788
Surgery in the first 24 h (yes) −0.332 0.154 .03 0.718 0.531 0.970
Admitting service/critical care (yes) 1.065 0.129 <.0001 2.901 2.253 3.735
Charlson grade (0 vs 3) −1.029 0.226 <.0001 0.357 0.230 0.556
Charlson grade (1 vs 3) −0.463 0.163 .005 0.629 0.457 0.867
Charlson grade (2 vs 3) −0.244 0.159 .12 0.783 0.574 1.069
Glasgow coma score −0.117 0.019 <.0001 0.890 0.857 0.924
Vent or NIPPV support in 24 h (yes) 0.924 0.145 <.0001 2.518 1.894 3.347
Any vasopressor support in 24 h (yes) 0.291 0.168 .08 1.338 0.962 1.861
Poly pharmacy (yes) −1.330 0.131 <.0001 0.264 0.205 0.342
First temperature −0.315 0.070 <.0001 0.730 0.636 0.838
First heart rate 0.010 0.003 .001 1.010 1.004 1.017
First respiratory rate 0.024 0.010 .01 1.025 1.005 1.044
First white blood count 0.010 0.003 .0001 1.010 1.005 1.015
First sodium −0.032 0.011 .003 0.968 0.947 0.989
First systolic blood pressure −0.004 0.002 .12 0.996 0.992 1.001
First BUN 0.008 0.002 .002 1.008 1.003 1.012
Missing vs abnormal bilirubin 0.917 0.791 .25 2.501 0.531 11.776
Normal vs abnormal bilirubin −0.245 0.150 .10 0.783 0.584 1.050
Missing vs abnormal albumin −1.353 0.790 .09 0.258 0.055 1.216
Normal vs abnormal albumin −0.332 0.171 .053 0.718 0.513 1.004
Missing vs abnormal base −0.696 0.173 <.0001 0.499 0.356 0.700
Normal vs abnormal base 0.045 0.174 .80 1.046 0.744 1.472
Missing vs abnormal INR −0.536 0.169 .002 0.585 0.420 0.814
Normal vs abnormal INR −0.151 0.155 .33 0.860 0.634 1.165
Intercept: 13.50 (standard error: 2.96)
Figure 1 A receiver operating characteristic (ROC) curve was used
to assess the accuracy of the predicted score in the derivation
sample.
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of medical information relevant to clinical care during transi-
tions of care.39
Our study has some limitations. We were able to predict 30-
day in-hospital deaths but were unable to predict earlier in-
hospital deaths due to a limited sample size. We do not have a
measure of clinician judgment regarding the risk of inpatient
mortality at the point of initial care on admission, which could
add additional predictive value. There may be relationships
between individual missing labs in specific populations (e.g.,
patients with sepsis) and the risk of mortality that we were
unable to distinguish. Longitudinal health care utilization data
from IHIE was obtained to support the analysis, but any
utilization data from health care systems not participating in
IHIE could not be included. Most of the variables used in this
model were readily available in the EMR within 24 h of
transfer except CCI scores, which may not be available on
day 1 of the hospitalization. Our next steps will be to revalidate
the model substituting CCI scores with the readily available
“medical problem list” and any other in-system diagnoses or
procedures as the source of comorbidity data. This was an
observational retrospective cohort single-center study among
diverse transferred patients, so its generalizability to other
specific inpatient populations is yet to be determined. Our
model may also be affected by lead-time bias and under-
predicted mortality in our cohort as we included vital signs
after arrival, but despite these potential issues, our model had
reasonable accuracy.10, 40 This model was developed and
validated prior to the COVID-19 pandemic, to further evaluate
its accuracy during a period of increased hospitalization and
mortality of seriously ill patients infected with severe acute
respiratory syndrome-coronavirus-2 (SARS-CoV-2) will need
to be examined. Lastly, the clinical implications of the asso-
ciation of the statistical significance of this model and the in-
hospital mortality must be interpreted with caution; this model
should invariably be used in the setting of a clinician’s judg-
ment and either to develop a palliative care response team to
address SIC early in the hospital course or for clinical docu-
mentation improvement efforts.
CONCLUSIONS
Our study shows that readily available EMR and administra-
tive data within the first 24 h of a hospital transfer is a
promising approach to predict the risk of 30-day in-hospital
mortality. This model has an excellent discriminatory ability
and clinically acceptable levels of sensitivity, specificity, and
positive predictive value. In subsequent work, we plan to use
this model early in the hospital course as an EMR trigger to
identify seriously ill transferred patients with a high risk of
mortality and facilitate timely SIC interventions. We also plan
to examine the model’s utility to trigger a check of the severity
of illness documentation and coding to improve the accuracy
of risk-stratified mortality indices.
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Table 4 Derivation Sample Model Performance by Specificity Levels (95%, 90%, 85%, 80%, 75%), n = 5194














−1.0013 277 4486 236 195 54.00 58.69 95.00
−1.7637 345 4250 472 127 42.23 73.09 90.00
−2.2065 377 4014 708 95 34.75 79.87 85.00
−2.5452 390 3778 944 82 29.24 82.63 80.00
−2.8106 408 3542 1180 64 25.69 86.44 75.01
Table 5 Validation Sample Model Performance by Specificity Levels (95%, 90%, 85%, 80%, 75%), n = 5195














−1.0013 250 4487 236 222 51.44 52.97 95.00
−1.7637 320 4272 451 152 41.50 67.80 90.45
−2.2065 356 4032 691 116 34.00 75.42 85.37
−2.5452 385 3770 953 87 28.77 81.57 79.82
−2.8106 405 3528 1195 67 25.31 85.81 74.70
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